217 related articles for article (PubMed ID: 16927532)
41. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
42. Anticarcinogenic and antimetastatic activity of Iscador.
Kuttan G; Menon LG; Antony S; Kuttan R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
[TBL] [Abstract][Full Text] [Related]
43. Successful treatment of metastatic malignant melanoma with Viscum album extract (Iscador M).
Kirsch A
J Altern Complement Med; 2007 May; 13(4):443-5. PubMed ID: 17532738
[TBL] [Abstract][Full Text] [Related]
44. Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts.
Knöpfl-Sidler F; Viviani A; Rist L; Hensel A
Pharmazie; 2005 Jun; 60(6):448-54. PubMed ID: 15997835
[TBL] [Abstract][Full Text] [Related]
45. Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses.
Twardziok M; Meierhofer D; Börno S; Timmermann B; Jäger S; Boral S; Eggert A; Delebinski CI; Seifert G
BMC Complement Altern Med; 2017 Apr; 17(1):237. PubMed ID: 28454538
[TBL] [Abstract][Full Text] [Related]
46. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
47. Effects of mistletoe extract on murine thymocytes in vivo and on glucocorticoid-induced cell count reduction.
Hajtó T; Berki T; Pálinkás L; Boldizsár F; Németh P
Forsch Komplementmed; 2006 Feb; 13(1):22-7. PubMed ID: 16582547
[TBL] [Abstract][Full Text] [Related]
48. Effect of a preparation from Viscum album on tumor development in vitro and in mice.
Kuttan G; Vasudevan DM; Kuttan R
J Ethnopharmacol; 1990 Apr; 29(1):35-41. PubMed ID: 2345458
[TBL] [Abstract][Full Text] [Related]
49. Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes.
Stein GM; Pfüller U; Schietzel M
Anticancer Res; 1999; 19(4B):2925-8. PubMed ID: 10652574
[TBL] [Abstract][Full Text] [Related]
50. Biologic properties of iscador: a Viscum album preparation I. Hyperplasia of the thymic cortex and accelerated regeneration of hematopoietic cells following X-irradiation.
Rentea R; Lyon E; Hunter R
Lab Invest; 1981 Jan; 44(1):43-8. PubMed ID: 7453129
[TBL] [Abstract][Full Text] [Related]
51. Donor-dependent and dose-dependent variation in the induction of T lymphocyte locomotion in a three-dimensional collagen matrix system by a mistletoe preparation (Iscador).
Nikolai G; Friedl P; Werner M; Zänker KS
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S61-4. PubMed ID: 9179371
[TBL] [Abstract][Full Text] [Related]
52. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
[TBL] [Abstract][Full Text] [Related]
53. Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Evid Based Complement Alternat Med; 2014; 2014():236310. PubMed ID: 24955100
[TBL] [Abstract][Full Text] [Related]
54. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2007 Jun; 14(3):140-7. PubMed ID: 17596694
[TBL] [Abstract][Full Text] [Related]
55. Local reactions to treatments with Viscum album L. extracts and their association with T-lymphocyte subsets and quality of life.
Büssing A; Tröger W; Stumpf C; Schietzel M
Anticancer Res; 2008; 28(3B):1893-7. PubMed ID: 18630477
[TBL] [Abstract][Full Text] [Related]
56. Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador.
Kuttan G; Menon LG; Kuttan R
Carcinogenesis; 1996 May; 17(5):1107-9. PubMed ID: 8640920
[TBL] [Abstract][Full Text] [Related]
57. Immunological mechanism of action of the tumor reducing peptide from mistletoe extract (NSC 635089) cellular proliferation.
Kuttan G; Kuttan R
Cancer Lett; 1992 Sep; 66(2):123-30. PubMed ID: 1394116
[TBL] [Abstract][Full Text] [Related]
58. Chemical specificity of effector cell/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cells.
Mueller EA; Anderer FA
Immunopharmacology; 1990; 19(1):69-77. PubMed ID: 2407685
[TBL] [Abstract][Full Text] [Related]
59. Effect of viscum album in the inhibition of lung metastasis in mice induced by B16F10 melanoma cells.
Antony S; Kuttan R; Kuttan G
J Exp Clin Cancer Res; 1997 Jun; 16(2):159-62. PubMed ID: 9261741
[TBL] [Abstract][Full Text] [Related]
60. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
